Kexian Zhu
Harvard University(US)Harvard Stem Cell Institute(US)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, Muscle Physiology and Disorders, Virus-based gene therapy research, Congenital heart defects research
Most-Cited Works
- → Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions(2012)1,795 cited
- → Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling(2012)1,730 cited
- → In vivo gene editing in dystrophic mouse muscle and muscle stem cells(2015)1,029 cited
- → A multifunctional AAV–CRISPR–Cas9 and its host response(2016)623 cited
- → Insulin Inhibits Cardiac Mesoderm, Not Mesendoderm, Formation During Cardiac Differentiation of Human Pluripotent Stem Cells and Modulation of Canonical Wnt Signaling Can Rescue This Inhibition(2012)74 cited
- → In Situ Modification of Tissue Stem and Progenitor Cell Genomes(2019)51 cited
- → A Small Molecule Inhibitor of Src Family Kinases Promotes Simple Epithelial Differentiation of Human Pluripotent Stem Cells(2013)36 cited
- → 483. In Vivo DMD Gene Editing in Muscles and Muscle Stem Cells of Dystrophic Mice(2016)2 cited
- → β-catenin expression remains constant during RA-induced epithelial differentiation.(2015)
- → RA-induced epithelial differentiation correlates with β-catenin membrane localization.(2015)